Indicative Announcement on Convening the 2025 Annual General Meeting
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Indicative Announcement on Convening the 2025 Annual General Meeting
Filed with SSE · · 6 pages · Chinese
Release
Zhejiang Hisun Pharmaceutical Co., Ltd. on 6ix
Earlier from Zhejiang Hisun Pharmaceutical
- Announcement on Preliminary Earnings Estimate for Q1 2026
- Announcement on Estimated Daily Related Party Transactions in 2026
- Announcement on the Implementation of Repurchase and Cancellation of Equity Incentive Restricted Stocks
- Announcement on Convening the 2025 Annual Performance Briefing
- Announcement on the Company's Drug Passing Consistency Evaluation of Generic Drug
Later from Zhejiang Hisun Pharmaceutical
- Report for Q1 2026
- Announcement on Resolutions of the 2025 Annual General Meeting
- Announcement on Outline of Reception Day for Investors
- Announcement on Obtaining Drug Registration Certificate
- Announcement on Implementation of Dividend Distribution for 2025
Follow Zhejiang Hisun Pharmaceutical into a list and get an email when it puts out news.
Follow Zhejiang Hisun Pharmaceutical